P3 Health Partners Inc (NASDAQ: PIII) on Tuesday, soared 2.44% from the previous trading day, before settling in for the closing price of $0.18. Within the past 52 weeks, PIII’s price has moved between $0.17 and $1.22.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 38.37% annually for the last half of the decade. The company achieved an average annual earnings per share of 11.08%. With a float of $91.41 million, this company’s outstanding shares have now reached $161.97 million.
In an organization with 400 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 21.57%, operating margin of -16.69%, and the pretax margin is -16.87%.
P3 Health Partners Inc (PIII) Insider and Institutional Ownership
Observing investor behavior towards Medical Care Facilities industry stocks is more important than anything else. The insider ownership of P3 Health Partners Inc is 43.87%, while institutional ownership is 21.12%. The most recent insider transaction that took place on Sep 12 ’24, was worth 41,600. In this transaction 10% Owner of this company bought 80,000 shares at a rate of $0.52, taking the stock ownership to the 77,105,438 shares. Before that another transaction happened on Sep 13 ’24, when Company’s 10% Owner bought 80,000 for $0.50, making the entire transaction worth $39,952. This insider now owns 77,185,438 shares in total.
P3 Health Partners Inc (PIII) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 11.08% per share during the next fiscal year.
P3 Health Partners Inc (NASDAQ: PIII) Trading Performance Indicators
P3 Health Partners Inc (PIII) is currently performing well based on its current performance indicators. A quick ratio of 0.53 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.05.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.84, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.40 in one year’s time.
Technical Analysis of P3 Health Partners Inc (PIII)
Let’s dig in a bit further. During the last 5-days, its volume was 0.88 million. That was inferior than the volume of 5.08 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 33.25%. Additionally, its Average True Range was 0.02.
During the past 100 days, P3 Health Partners Inc’s (PIII) raw stochastic average was set at 4.36%, which indicates a significant decrease from 32.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 60.63% in the past 14 days, which was lower than the 114.85% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2119, while its 200-day Moving Average is $0.4293. However, in the short run, P3 Health Partners Inc’s stock first resistance to watch stands at $0.1962. Second resistance stands at $0.2034. The third major resistance level sits at $0.2112. If the price goes on to break the first support level at $0.1812, it is likely to go to the next support level at $0.1734. The third support level lies at $0.1662 if the price breaches the second support level.
P3 Health Partners Inc (NASDAQ: PIII) Key Stats
Market capitalization of the company is 67.85 million based on 358,820K outstanding shares. Right now, sales total 1,266 M and income totals -57,770 K. The company made 362,120 K in profit during its latest quarter, and -46,510 K in sales during its previous quarter.
